Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke: An Updated Systematic Review and Meta-Analysis

Study Questions:

What is the overall effect of intravenous recombinant tissue plasminogen activator (rt-PA) when given up to 6 hours after stroke for important early and late outcomes?